Nobel Prize-winning scientist Venki Ramakrishnan considers both why we might live longer, and the dilemmas this raises. In the last few years, medical advances have led to treatments that really do offer the potential to tackle life-threatening cancers and debilitating diseases such as Parkinson’s and Alzheimer’s. In discussion with Nuala McGovern, Venki also explores the questions such treatments raise. Initially, they will be expensive, and we already have a global society in which there is a direct link between life expectancy and affluence; will access to these treatments, or lack of it, increase that disparity? And although your incurable disease may now be cured, what about the rest of your quality of life? Can the planet support an increasingly needy older and older generation? Does trying to live longer become a selfish act?Nobel Prize-winning molecular biologist Venki Ramakrishnan heads a research group at the MRC Laboratory of Molecular Biology in Cambridge, England.This is the first in a series of four programmes from the Oxford Literary Festival, presented by Nuala McGovern and produced by Julian Siddle.Recorded in front of an audience at Worcester College, Oxford.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
#2426 - Cameron Hanes & Adam Greentree
16 Dec 2025
The Joe Rogan Experience
#2425 - Ethan Hawke
11 Dec 2025
The Joe Rogan Experience
SpaceX Said to Pursue 2026 IPO
10 Dec 2025
Bloomberg Tech
Don’t Call It a Comeback
10 Dec 2025
Motley Fool Money
Japan Claims AGI, Pentagon Adopts Gemini, and MIT Designs New Medicines
10 Dec 2025
The Daily AI Show
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare